Experimental treatment with ticagrelor monotherapy benefits non-obese ACS patients

Experimental treatment with ticagrelor monotherapy benefits non-obese ACS patients

2020.02.24

A subgroup analysis of a large, multicentre, randomized controlled trial has demonstrated a beneficial effect of ticagrelor monotherapy in non-obese acute coronary syndrome (ACS) patients.The GLOBAL...

Chinese researchers predict the risk of new-onset ACS in patients with diabetes

Chinese researchers predict the risk of new-onset ACS in patients with diabetes

2020.02.21

Researchers have developed a potent risk predictive model to predict the probability of new-onset acute coronary syndrome (ACS) in patients with type 2 diabetes mellitus (T2DM), using data from the...

Octogenarians with ACS expect their treatment to result in increased wellbeing and fewer symptoms

Octogenarians with ACS expect their treatment to result in increased wellbeing and fewer symptoms

2020.02.17

Researchers have collected valuable insights into the preferences and expectations of elderly people for acute coronary syndrome (ACS) treatment, helping to add to the evidence about whether this...

Smoking impacts mortality post-PCI

Smoking impacts mortality post-PCI

2020.02.14

Current smokers undergo percutaneous coronary intervention (PCI) at a younger age and have higher short-term mortality compared with ex-smokers and never smokers, according to results from a...

Blood platelet count at hospital admission impacts long-term mortality in ACS patients

Blood platelet count at hospital admission impacts long-term mortality in ACS patients

2020.02.10

Patients with acute coronary syndrome (ACS) and who have thrombocytopenia or thrombocytosis at hospital admission have almost twice the mortality rate at 5 years compared with those with normal blood...

Atrial fibrillation is an independent predictor for adverse in-hospital outcome in ACS

Atrial fibrillation is an independent predictor for adverse in-hospital outcome in ACS

2020.02.07

A study in Italy has shown atrial fibrillation is an independent predictor for adverse in-hospital outcome in acute coronary syndrome (ACS), but this effect disappeared at 6 months’ follow-up,...

GRACE score useful for patients with SCAD after PCI

GRACE score useful for patients with SCAD after PCI

2020.02.03

The Global Registry of Acute Coronary Events (GRACE) discharge score is valuable for patients with stable coronary artery disease (SCAD) after percutaneous coronary intervention (PCI). In a...

No association between ACS and telomeres in older patients

No association between ACS and telomeres in older patients

2020.01.31

Researchers have not found a link between short telomeres or low telomerase activity and poor outcomes in older patients with non-ST elevation acute coronary syndrome (NSTEACS) undergoing invasive...

Atherosclerosis gene linked with increased risk of ACS in Chinese Han

Atherosclerosis gene linked with increased risk of ACS in Chinese Han

2020.01.27

A gene associated with the pathogenesis of atherosclerosis has been linked with an increased risk of acute coronary syndrome (ACS) in a population of Chinese Han.Researchers have long recognized that...

Ticagrelor associated with 31% MACCE reduction compared to clopidogrel in elderly patients with STEMI

Ticagrelor associated with 31% MACCE reduction compared to clopidogrel in elderly patients with STEMI

2020.01.24

Researchers have confirmed the efficacy and safety of ticagrelor for elderly patients (≥75 years) with acute ST‐segment–elevation myocardial infarction (STEMI), compared with clopidogrel.The...